CHARLES M BAUM
CIK 1579824 · Founder, President, and CEO · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$13.9K
Companies
5
Total Filings
71
Lifetime Open-Market Net
-$47.82M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PMVP | Director | — | $1.11 | — | $0 | 7 | 2026-06-05 |
| ACRV | Director | 9,366 | $1.48 | $13.9K | $0 | 4 | 2026-05-20 |
| Poseida Therapeutics, Inc. (PSTX) Delisted | Director | 0 | $9.50 | $0 | $0 | 4 | 2025-01-08 |
| Mirati Therapeutics, Inc. (MRTX) Delisted | Founder, President, and CEO | 114,482 | $58.70 | $6.72M | -$47.82M | 42 | 2024-01-23 |
| IMMUNOMEDICS INC (IMMU) Delisted | Director | 0 | — | — | $0 | 4 | 2020-10-23 |
Recent Filings · Page 6 of 8
71 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-10-29 | — | Mixed | +5,000 | $0 | |
| 2018-08-24 | Mirati Therapeutics, Inc. (MRTX) Delisted | Mixed | +11,486 | -$2.34M | EDGAR |
| 2018-02-27 | Mirati Therapeutics, Inc. (MRTX) Delisted | Mixed | — | -$1.01M | EDGAR |
| 2018-02-12 | — | Mixed | — | -$568.0K | |
| 2018-01-22 | Mirati Therapeutics, Inc. (MRTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-10-27 | — | Mixed | +5,000 | $52.4K | |
| 2017-05-11 | Mirati Therapeutics, Inc. (MRTX) Delisted | Mixed | — | $0 | EDGAR |
| 2017-03-30 | — | Mixed | — | -$135.0K | |
| 2017-01-30 | Mirati Therapeutics, Inc. (MRTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-10-31 | — | Mixed | +5,000 | $29.1K |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.